Literature DB >> 18983946

Association between serum cholesterol and bone mineral density.

Joanna Makovey1, Jian Sheng Chen, Chris Hayward, Frances M K Williams, Philip N Sambrook.   

Abstract

BACKGROUND: Hypercholesterolaemia has been associated with low bone mineral density (BMD) in some but not all studies.
OBJECTIVES: To examine the influence of age, menopausal status and hormone replacement therapy (HRT) on the relationship between serum cholesterol and BMD in women. PATIENTS AND MEASUREMENTS: 497 female participants (age range 20-81) comprising 224 premenopausal and 273 postmenopausal women (156 on HRT and 117 no HRT) underwent measurements of bone mineral density (BMD) and serum lipid profile.
RESULTS: Total serum cholesterol (TC) and low density lipoprotein (LDL) levels were higher and lumbar spine BMD was lower in postmenopausal women not taking HRT compared to those taking HRT. TC and LDL were negatively associated with BMD at all measured sites among postmenopausal women not taking HRT in univariate regression analysis (all p<0.05). High density lipoprotein (HDL) had inverse relationships with BMD at all sites in pre-menopausal women and those who were exposed to HRT (p<0.05). In fully adjusted regression models the relationships between TC and BMD remained significant at the lumbar spine and whole body (p<0.05) and between LDL and lumbar spine BMD only (p<0.05). For subjects in the other groups, no significant associations between TC or LDL and BMD were found. Significant interactions between total cholesterol and LDL levels with HRT were detected among post-menopausal women in the regression analyses (all p<0.05). No such interactions were found between HDL levels and HRT.
CONCLUSION: There is a modest inverse relationship between lumbar spine and whole body BMD and serum TC and LDL levels and in post-menopausal women and HDL in pre-menopausal women. HRT use appears to modify these relationships. The mechanisms of this relationship require further study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983946     DOI: 10.1016/j.bone.2008.09.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  43 in total

1.  New Clues that May Link Osteoporosis to the Circulating Lipid Profile.

Authors:  Catalina Poiana; Valentin Radoi; Mara Carsote; John P Bilezikian
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

2.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 3.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

4.  High cholesterol diet increases osteoporosis risk via inhibiting bone formation in rats.

Authors:  Li You; Zheng-yan Sheng; Chuan-ling Tang; Lin Chen; Ling Pan; Jin-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

5.  Low bone mineral density is associated with increased risk for myocardial infarction in men and women.

Authors:  P Wiklund; A Nordström; J-H Jansson; L Weinehall; P Nordström
Journal:  Osteoporos Int       Date:  2011-04-20       Impact factor: 4.507

Review 6.  Should we abandon statins in the prevention of bone fractures?

Authors:  Katherine Esposito; Annalisa Capuano; Liberata Sportiello; Andrea Giustina; Dario Giugliano
Journal:  Endocrine       Date:  2013-03-24       Impact factor: 3.633

7.  Predictors of low bone mineral density of the stroke-affected hip among ambulatory individuals with chronic stroke.

Authors:  S Marzolini; W McIlroy; A Tang; D Corbett; B C Craven; P I Oh; D Brooks
Journal:  Osteoporos Int       Date:  2014-07-08       Impact factor: 4.507

8.  Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men.

Authors:  A L Kuipers; I Miljkovic; R Evans; C H Bunker; A L Patrick; J M Zmuda
Journal:  Osteoporos Int       Date:  2015-11-24       Impact factor: 4.507

9.  Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss.

Authors:  Zu-Guo Zheng; Hui-Min Cheng; Ya-Ping Zhou; Si-Tong Zhu; Pyone Myat Thu; Hui-Jun Li; Ping Li; Xiaojun Xu
Journal:  Cell Death Differ       Date:  2020-01-06       Impact factor: 15.828

Review 10.  Lipids in the Bone Marrow: An Evolving Perspective.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Cell Metab       Date:  2019-10-24       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.